Physician profile
Judith H Hoffman
NPI 1952407934
$1,543.60
in general payments reported to CMS, 2019-2025
14 companies · $270 in 2025
The $270 reported for 2025 was more than what 82% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.08 · 2020: $103 · 2021: $151 · 2022: $360 · 2023: $267 · 2024: $334 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $870.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $635.41 | 2019-2025 | Bexsero, Penmenvy, Pediarix |
| Kaleo, INC. | $288.43 | 2020-2024 | Auvi-Q |
| Merck Sharp & Dohme LLC | $152.65 | 2022-2025 | Gardasil 9, M-M-R II, Vaxneuvance |
| Seqirus USA INC | $70.53 | 2021-2025 | Flucelvax, Flucelvax Quadrivalent |
| Pfizer INC. | $65.48 | 2019-2023 | |
| Sanofi Pasteur INC. | $63.58 | 2019-2025 | |
| Ironshore Pharmaceuticals INC. | $58.37 | 2024 | |
| Collegium Pharmaceutical, INC. | $58.03 | 2025 | Jornay Pm |
| Phadia US INC. | $40.62 | 2023-2024 | Immunocap |
| Hologic Sales and Service, LLC | $26.54 | 2023 | Aptima |
| Theratechnologies INC. | $25.56 | 2024 | Trogarzo, Egrifta |
| Alk-Abello, INC | $22.39 | 2025 | Neffy |
| Sobi, INC | $19.77 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.24 | 2023 | Flumist Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.